Israeli technology monitors cell death in cancer treatment
An Israeli company called Aposense has developed technology to monitor cell death in cancer treatment (Hat Tip: Instapundit).When it comes to aggressive cancers, in the brain or lung for example, oncologists know that the sooner they can determine whether a treatment is unsuccessful, the sooner they can reevaluate and, if necessary, prescribe a new course of action. But typically, it takes two months or more to do the before-and-after comparisons that help determine whether a tumor is shrinking. Now an Israeli company called Aposense says it may have found a way to drastically speed up the process: an imaging marker that, when used with PET scans, indicates the presence of dying cells.Read the whole thing.
Apoptosis, the process by which cells commit suicide, is a vital mechanism in the body that weeds out damaged, infected, or otherwise unhealthy cells. No matter what the disease or the tissue, cells undergoing apoptosis have very distinct characteristics--the electrical profile of their membrane changes, the cells become more acidic, and lipids in the membrane lose their rigid order and become jumbled. Aposense believes it has found a way to target a trace marker to this combination of traits, which would let doctors image cell death and thereby determine whether radiation and chemotherapy are working within just a few days after treatment begins.
As Glenn would say, "faster, faster."
1 Comments:
Unfortunately most PET applications are yet to be approved in the US
Post a Comment
<< Home